|New Threads Only:|
|New Threads & Replies:|
Forum List » Guru News and Commentaries|
Guru News, Stock picks and commentaries
Carl Icahn Added 7.44% to His Stake in Forest Laboratories at the Average Price of $34
Posted by: GuruFocus (IP Logged)
Date: August 23, 2012 05:58PM
Carl Icahn added 7.44% to his stake in Forest Laboratories Inc. (FRX) at the average price of $34.33 on 08/21/2012, as reported in the latest insider filings by Carl Icahn. He owns 28,323,697 shares. Forest Laboratories Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Forest Laboratories Inc. has a market cap of $9.09 billion; its shares were traded at around $34.66 with a P/E ratio of 11.6 and P/S ratio of 2. Forest Laboratories Inc. had an annual average earnings growth of 9.7% over the past 10 years. GuruFocus rated Forest Laboratories Inc. the business predictability rank of 4-star.
Several gurus hold positions in FRX. Richard Pzena owns 11,128 shares as of 06/30/2012, an increase of 231.88% from the previous quarter. This position accounts for 0.0045% of the $8.56 billion portfolio of Pzena Investment Management LLC. Joel Greenblatt owns 379,743 shares as of 06/30/2012, which accounts for 0.98% of the $1.36 billion portfolio of Gotham Capital. John Hussman owns 350,000 shares as of 06/30/2012, which accounts for 0.23% of the $5.32 billion portfolio of Hussman Economtrics Advisors.
Forest Laboratories recently announced that reported earnings per share equaled $0.21 in the first quarter of fiscal 2013. Reported earnings per share in the first quarter of fiscal 2012 were $0.90 after a charge of $40.0 million or $0.14 per share net of tax. Net sales for the quarter decreased 31.9% to $751.8 million, from $1.1 billion in the year-ago period.
Director Lester B. Salans sold 2,390 shares of FRX stock on 04/18/2012 at the average price of $34.30. Lester B. Salans owns at least 21,512 shares after this. The price of the stock has increased by 1.05% since. Other insiders have also decreased their positions in the company.
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.